Midazolam: Supply issue resolved

Baxter's brand of Midazolam (Midazolam-Claris) 1mg per ml, 5mg injection was out of stock from 28 February 2021 to early June 2021.

Update 9 June 2021

We understand that the stock has arrived and been released. Talk to your wholesaler about when Baxter-Midazolam will be available.  

The delisting date for the Mylan product is likely to be 1 January 2022. 

Background

The out of stock was caused by the current stock expiring at the end of February and Baxter’s replacement brand Midazolam-Baxter not yet being available.

To ensure continuity of supply, an alternative brand of Midazolam supplied by Mylan was listed in the Community Pharmaceutical Schedule from 1 February 2021. (It was already listed in the HML)

Details of the alternative product are as follows:

  • Chemical and presentation: Midazolam inj 1 mg per ml, 5 ml ampoule
  • Brand: Mylan Midazolam
  • Pack Size: 10
  • Subsidy and price (ex-man., ex. GST): $2.98
  • Pharmacode: 2474468

RxOne users: the new listings and changes will be automatically updated by RxOne. If for some unforeseen circumstance it does not happen, please refer to the e-Noticeboard on the RxOne Home Screen for instructions.

TONIQ users: the new listings and changes will automatically be updated in Toniq medicine databases from the effective date.

Please note that Ministry of Health Sector Operations Group will be able to process claims for February 2021 dispensing of the above listing.

Check the Midazolam listing on the Schedule

Who to contact

If you have any questions about changing brands, talk with your doctor, nurse, or pharmacist.

If you have questions about funding for Midazolam, contact PHARMAC: